Yorke Justin W. - 10 Oct 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
10 Oct 2023
Net transactions value
+$2,520
Form type
4
Filing time
10 Oct 2023, 16:58:16 UTC
Previous filing
24 Jul 2023
Next filing
23 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $2,520 +12,000 +21% $0.2100 69,729 10 Oct 2023 Direct
holding PCSA Common Stock 519,890 10 Oct 2023 By Richland Fund, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.